InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 11.15
-0.30 (-2.62%)
Aug 19, 2026, 1:52 PM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.19 billion as of August 19, 2026. Its market cap has decreased by -47.14% in one year.
Market Cap
1.19B
Enterprise Value
942.11M
Revenue
67.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.15
ChartMarket Cap Chart
Since September 13, 2012, InnoPharmax's market cap has decreased from 1.54B to 1.19B, a decrease of -22.55%. That is a compound annual growth rate of -1.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.19B | -33.93% |
| Dec 31, 2025 | 1.81B | 3.38% |
| Dec 31, 2024 | 1.75B | 5.76% |
| Dec 29, 2023 | 1.65B | 62.70% |
| Dec 30, 2022 | 1.02B | -32.67% |
| Dec 30, 2021 | 1.51B | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PhytoHealth | 2.19B |
| TSH Biopharm Corporation | 1.94B |
| GeneFerm Biotechnology | 1.25B |
| Excelsior Biopharma | 1.15B |
| Prince Pharmaceutical | 1.09B |
| DV Biomed | 1.03B |
| Original BioMedicals | 942.23M |
| Winston Medical Supply | 920.85M |